0001493152-24-010419.txt : 20240319 0001493152-24-010419.hdr.sgml : 20240319 20240319070016 ACCESSION NUMBER: 0001493152-24-010419 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240319 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enveric Biosciences, Inc. CENTRAL INDEX KEY: 0000890821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 954484725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38286 FILM NUMBER: 24761060 BUSINESS ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 BUSINESS PHONE: 239-302-1707 MAIL ADDRESS: STREET 1: 4851 TAMIAMI TRAIL N, SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 FORMER COMPANY: FORMER CONFORMED NAME: AMERI Holdings, Inc. DATE OF NAME CHANGE: 20150527 FORMER COMPANY: FORMER CONFORMED NAME: SPATIALIZER AUDIO LABORATORIES INC DATE OF NAME CHANGE: 19950323 8-K 1 form8-k.htm
false 0000890821 0000890821 2024-03-19 2024-03-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

March 19, 2024

Date of Report (Date of earliest event reported)

 

Enveric Biosciences, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38286   95-4484725

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

 

Enveric Biosciences, Inc.

4851 Tamiami Trail N, Suite 200

Naples, FL 34103

(Address of principal executive offices) (Zip code)

 

Registrant’s telephone number, including area code: (239) 302-1707

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.01 per share   ENVB   The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 7.01 Regulation FD Disclosure.

 

On March 19, 2024, Enveric Biosciences, Inc. (the “Company”) published a press release announcing entering into two non-binding term sheets to pursue the exclusive out-licensing of new chemical entities for pharmaceutical and non-pharmaceutical applications in joint disease. A copy of such press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

 

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit Number

   Description
     
99.1   Press Release, dated March 19, 2024 (furnished pursuant to Item 7.01)
104   Cover Page Interactive Data File (formatted as Inline XBRL)

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 19, 2024 ENVERIC BIOSCIENCES, INC.
     
  By: /s/ Joseph Tucker
    Joseph Tucker, Ph.D.
    Chief Executive Officer

 

 

 EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive

Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease

 

Second biotechnology company to potentially out-license novel compounds from

Enveric’s portfolio of assets with possible significant milestone payments and royalties

 

CAMBRIDGE, Mass., March 19, 2024 – Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, is pleased to announce that it has signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for both pharmaceutical and non-pharmaceutical applications for treatment of joint diseases.

 

The term sheets contemplate that, for all human and animal joint pathology, such as osteoarthritis, rheumatoid arthritis, and other joint pathology applications, the undisclosed licensee would assume responsibility for all future product development efforts and in return would receive exclusive, royalty-bearing global licenses to develop, market and sublicense the compounds. The compounds are new chemical entities that include cannabinoids in conjugate form with COX-2 inhibitors and cannabinoids in conjugate form with selected steroids.

 

The pharmaceutical application term sheet provides that Enveric could be eligible to receive future development and sales milestone payments that in total could add up to approximately $61 million, assuming certain conditions are met, including receiving approval for the investigational new drug (IND) application and completing Phases I through III testing of the licensed product. Royalty rates could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria.

 

The non-pharmaceutical application term sheet provides that Enveric could be eligible to receive future development and sales milestone payments, which in total could add up to approximately $21 million and with royalty rates ranging from 0.25% up to 7%, assuming certain conditions are met, including successful product development and commercial launch and on meeting certain sales criteria.

 

Together, through the out-licensing of the two assets and meeting various development and sales milestones, Enveric could potentially receive milestone payments that total up to approximately $82 million.

 

“We are pleased to announce that a second biotechnology company has stepped forward looking to join Enveric in moving some of the Company’s promising assets forward,” said Joseph Tucker, Ph.D., Director and CEO of Enveric. “We look forward to working with our partner, and we are confident in their leadership and capabilities to continue the development of these compounds for both pharmaceutical and non-pharmaceutical applications to advance joint disease treatment options for patients. Ultimately, we believe the definitive licensing agreements, once negotiated and finalized, could represent an excellent potential source of revenue for Enveric, and continue to demonstrate the value of Enveric’s extensive portfolio of assets.”

 

 
 

 

 

About Enveric Biosciences

 

Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its unique discovery and development platform, Psybrary™, Enveric has created a robust intellectual property portfolio of new chemical entities for specific mental health indications. Enveric’s lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders. Enveric is headquartered in Naples, FL with offices in Cambridge, MA and Calgary, AB Canada. For more information, please visit www.enveric.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans,” “expects” or “does not expect,” “proposed,” “is expected,” “budgets,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” or “believes,” or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, should, would, or might occur or be achieved. Forward-looking statements may include historical statements and statements regarding beliefs, plans, expectations, or intentions regarding the future and are based on the beliefs of management as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including, but not limited to, the ability of Enveric to: negotiate and finalize definitive agreements based on the any of its out-licensing term sheets, including the two identified herein, and perform pursuant to the terms thereof; carry out successful clinical programs in Australia; achieve the value creation contemplated by technical developments; avoid delays in planned clinical trials; establish that potential products are efficacious or safe in preclinical or clinical trials; establish or maintain collaborations for the development of therapeutic candidates; obtain appropriate or necessary governmental approvals to market potential products; obtain future funding for product development and working capital on commercially reasonable terms; scale-up manufacture of product candidates; respond to changes in the size and nature of competitors; hire and retain key executives and scientists; secure and enforce legal rights related to Enveric’s products, including patent protection; identify and pursue alternative routes to capture value from its research and development pipeline assets; continue as a going concern; and manage its future growth effectively. The two out-licensing term sheets identified herein are non-binding and may not result in definitive agreements or attainment of the licensing fees referenced therein.

 

A discussion of these and other factors, including risks and uncertainties with respect to Enveric, is set forth in Enveric’s filings with the Securities and Exchange Commission, including Enveric’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Enveric disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

Contact

Investor Relations 

Tiberend Strategic Advisors, Inc.

Daniel Kontoh-Boateng

(862) 213-1398

dboateng@tiberend.com

 

Media Relations

Tiberend Strategic Advisors, Inc.

Casey McDonald

(646) 577-8520

cmcdonald@tiberend.com

 

 

 

 GRAPHIC 3 image_001.jpg begin 644 image_001.jpg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end EX-101.SCH 4 envb-20240319.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 envb-20240319_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 envb-20240319_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover
Mar. 19, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 19, 2024
Entity File Number 001-38286
Entity Registrant Name Enveric Biosciences, Inc.
Entity Central Index Key 0000890821
Entity Tax Identification Number 95-4484725
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One Enveric Biosciences, Inc.
Entity Address, Address Line Two 4851 Tamiami Trail N
Entity Address, Address Line Three Suite 200
Entity Address, City or Town Naples
Entity Address, State or Province FL
Entity Address, Postal Zip Code 34103
City Area Code (239)
Local Phone Number 302-1707
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, par value $0.01 per share
Trading Symbol ENVB
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://enveric.com/role/Cover Cover Cover 1 false false All Reports Book All Reports envb-20240319.xsd envb-20240319_lab.xml envb-20240319_pre.xml form8-k.htm http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "ENVB", "nsuri": "http://enveric.com/20240319", "dts": { "schema": { "local": [ "envb-20240319.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "envb-20240319_lab.xml" ] }, "presentationLink": { "local": [ "envb-20240319_pre.xml" ] }, "inline": { "local": [ "form8-k.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://enveric.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-03-19", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-19", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://enveric.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001493152-24-010419-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-010419-xbrl.zip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form8-k_htm.xml IDEA: XBRL DOCUMENT 0000890821 2024-03-19 2024-03-19 iso4217:USD shares iso4217:USD shares false 0000890821 8-K 2024-03-19 Enveric Biosciences, Inc. DE 001-38286 95-4484725 Enveric Biosciences, Inc. 4851 Tamiami Trail N Suite 200 Naples FL 34103 (239) 302-1707 false false false false Common stock, par value $0.01 per share ENVB NASDAQ false